Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: A meta-analysis based on individual patient data.
Verrijssen AS, Guillem J, Perez R, Bujko K, Guedj N, Habr-Gama A, Houben R, Goudkade D, Melenhorst J, Buijsen J, Vanneste B, Grabsch HI, Bellezzo M, Paiva Fonseca G, Verhaegen F, Berbee M, Van Limbergen EJ. Verrijssen AS, et al. Among authors: melenhorst j. Radiother Oncol. 2020 Mar;144:37-45. doi: 10.1016/j.radonc.2019.10.003. Epub 2019 Nov 9. Radiother Oncol. 2020. PMID: 31710942 Free PMC article. Review.
BioXmark® liquid fiducials to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial.
Opbroek TJS, Willems YCP, Verhaegen F, de Ridder R, Hoge C, Melenhorst J, Bakers F, Grabsch HI, Buijsen J, Van Limbergen EJ, Canters RAM, Berbée M. Opbroek TJS, et al. Among authors: melenhorst j. Clin Transl Radiat Oncol. 2022 Nov 4;38:90-95. doi: 10.1016/j.ctro.2022.10.013. eCollection 2023 Jan. Clin Transl Radiat Oncol. 2022. PMID: 36407490 Free PMC article.
Abandonment of Routine Radiotherapy for Nonlocally Advanced Rectal Cancer and Oncological Outcomes.
Hazen SJA, Sluckin TC, Intven MPW, Beets GL, Beets-Tan RGH, Borstlap WAA, Buffart TE, Buijsen J, Burger JWA, van Dieren S, Furnée EJB, Geijsen ED, Hompes R, Horsthuis K, Leijtens JWA, Maas M, Melenhorst J, Nederend J, Peeters KCMJ, Rozema T, Tuynman JB, Verhoef C, de Vries M, van Westreenen HL, de Wilt JHW, Zimmerman DDE, Marijnen CAM, Tanis PJ, Kusters M; Dutch Snapshot Research Group. Hazen SJA, et al. Among authors: melenhorst j. JAMA Oncol. 2024 Feb 1;10(2):202-211. doi: 10.1001/jamaoncol.2023.5444. JAMA Oncol. 2024. PMID: 38127337
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
Fernandez LM, São Julião GP, Figueiredo NL, Beets GL, van der Valk MJM, Bahadoer RR, Hilling DE, Meershoek-Klein Kranenbarg E, Roodvoets AGH, Renehan AG, van de Velde CJH, Habr-Gama A, Perez RO; International Watch & Wait Database Consortium. Fernandez LM, et al. Lancet Oncol. 2021 Jan;22(1):43-50. doi: 10.1016/S1470-2045(20)30557-X. Epub 2020 Dec 11. Lancet Oncol. 2021. PMID: 33316218
Selected stage IV rectal cancer patients managed by the watch-and-wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery?
Custers PA, Hupkens BJP, Grotenhuis BA, Kuhlmann KFD, Breukink SO, Beets GL, Melenhorst J; Dutch Watch-and-Wait Consortium (collaborators). Custers PA, et al. Among authors: melenhorst j. Colorectal Dis. 2022 Apr;24(4):401-410. doi: 10.1111/codi.16034. Epub 2022 Jan 21. Colorectal Dis. 2022. PMID: 35060263 Free PMC article.
285 results